LM-299
LM-299 is a bispecific antibody targeting PD-1 and VEGF with anti-tumor activity. The dual binding activity of LM-299 is achieved through the effective binding of its Fab-terminal anti-VEGF-A antibody to human VEGF-A, as well as the blocking effect of its Fc-terminal anti-PD-1 antibody on the PD-1/PD-L1 pathway. LM-299 binds to and modulates PD-1 and VEGF. LM-299 can be used in studies related to advanced malignant tumors, advanced solid tumors, and advanced non-small cell lung cancer.
For research use only. We do not sell to patients.
- Purity: 95.78%
- Molecular Weight:175.49 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All VEGFR Isoforms
More
Biological Activity
Human IgG1 kappa
Human
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
PD-1 & VEGF
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Tetravalent IgG-VHH
ELISA, FACS, Functional assay
-
Immobilized Human PD-1 Protein, His Tag can bind LM-299. The EC50 for this effect is 164.3 ng/mL. -
Immobilized Human VEGF165 Protein,hFc Tag can bind LM-299. The EC50 for this effect is 77.9 ng/mL.
Chemical Information
-
Appearance Liquid
-
Molecular Weight 175.49 kDa
-
Color Colorless to light yellow
-
SMILES
[LM-299]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (256 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)